Stock News & Analysis

These companies haven't said their last words.

SoundHound is growing enterprise voice AI revenue across multiple industries with improving commercial momentum. BigBear.ai has sticky government contracts but declining revenue and heavy customer concentration risk.

The voice artificial intelligence company has a lot of potential, but its stock has been in a tailspin for much of the year.

Trademark Coca-Cola volume just posted its strongest gain in 17 years.

Vanguard's international fund offers lower costs and higher yield, but iShares' concentrated U.S. strategy delivered stronger performance over five years.

Even small investments, made consistently over time, can turn into huge sums of money.

Tech stocks drive most index funds, so why not focus exclusively on tech?

Both companies are losing money and asking investors to be patient, but one is at least growing its revenue while the other has seen sales decline.

You become eligible for Social Security benefits at 62, but don't make any decisions without knowing these facts.

I don't have a crystal ball, but here's a completely reasonable scenario for Nvidia investors to expect.

This new stablecoin has an important twist that makes it likely to be very successful.

Bloom Energy is expanding to satisfy its growing backlog.

Rocket Lab's business has been booming, and a successful Neutron launch could send the stock soaring yet again.

There's a difference between bad companies and good companies whose stock prices fall.

This under-the-radar industrial real estate stock boasts a Superscore of 72 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Alibaba trades at a cheaper valuation, but Uber's margin expansion and stronger free cash flow tell a different profitability story.

The stock market has been a terrific wealth builder over many long periods -- and it can even serve those of modest means.

Owning a low-cost index fund is one of the simplest ways to build wealth in the stock market over the long term.

If you think the world's most valuable company is cruising for a bruising, there is something you should look at first.

Even in a recession, there's strong demand for J&J's myriad of pharmaceutical and healthcare products.